These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 12168081

  • 1. Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
    Ferrari S, Rovati B, Cucca L, Scarabelli C, Presti M, Beccaria C, Collovà E, Porta C, Danova M.
    Oncol Rep; 2002; 9(5):1107-13. PubMed ID: 12168081
    [Abstract] [Full Text] [Related]

  • 2. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
    Bisset LR, Lung TL, Kaelin M, Ludwig E, Dubs RW.
    Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
    [Abstract] [Full Text] [Related]

  • 3. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.
    Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto F, Modesti M, Quaglino D.
    Am J Hematol; 2001 Jun; 67(2):63-72. PubMed ID: 11343377
    [Abstract] [Full Text] [Related]

  • 4. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
    Ashihara E, Shimazaki C, Yamagata N, Hirata T, Okawa K, Oku N, Goto H, Inaba T, Fujita N, Nakagawa M.
    Bone Marrow Transplant; 1994 Apr; 13(4):377-81. PubMed ID: 7912603
    [Abstract] [Full Text] [Related]

  • 5. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A, Koutsoukou V, Terpos E, Tsiatas ML, Liakos C, Tsitsilonis O, Rodolakis A, Voulgaris Z, Vlahos G, Papageorgiou T, Papatheodoridis G, Archimandritis A, Antsaklis A, Dimopoulos MA.
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [Abstract] [Full Text] [Related]

  • 6. [Phase II clinical study of topotecan hydrochloride in patients with recurrent advanced ovarian cancer].
    Li JD, Guan ZZ, Liu JH, Xin XY, Cui Y, Huang CJ, Liu FY, Song L, Bian ML, Zhou QH.
    Ai Zheng; 2002 Apr; 21(4):416-20. PubMed ID: 12452024
    [Abstract] [Full Text] [Related]

  • 7. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A, Tsiatas ML, Kafantari E, Liakou C, Rodolakis A, Voulgaris Z, Vlahos G, Papageorgiou T, Tsitsilonis O, Bamia C, Papatheodoridis G, Politi E, Archimandritis A, Antsaklis A, Dimopoulos MA.
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer.
    Gordon AN, Tonda M, Sun S, Rackoff W, Doxil Study 30-49 Investigators.
    Gynecol Oncol; 2004 Oct; 95(1):1-8. PubMed ID: 15385103
    [Abstract] [Full Text] [Related]

  • 9. Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Meier W, du Bois A, Reuss A, Kuhn W, Olbricht S, Gropp M, Richter B, Lück HJ, Kimmig R, Pfisterer J.
    Gynecol Oncol; 2009 Aug; 114(2):199-205. PubMed ID: 19446314
    [Abstract] [Full Text] [Related]

  • 10. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly.
    Provinciali M, Moresi R, Donnini A, Lisa RM.
    Gerontology; 2009 Aug; 55(3):314-21. PubMed ID: 19190395
    [Abstract] [Full Text] [Related]

  • 11. Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications.
    Ferrandina G, Pierelli L, Perillo A, Rutella S, Ludovisi M, Leone G, Mancuso S, Scambia G.
    Clin Cancer Res; 2003 Jan; 9(1):195-200. PubMed ID: 12538469
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD, Patel J, Schwab H, Martinez J.
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [Abstract] [Full Text] [Related]

  • 14. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.
    Le T, Leis A, Pahwa P, Wright K, Ali K, Reeder B, Hopkins L, Fung MF.
    Gynecol Oncol; 2004 Mar; 92(3):839-44. PubMed ID: 14984950
    [Abstract] [Full Text] [Related]

  • 15. Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer.
    Chiara S, Tognoni A, Pastrone I, Tomasello L, Brema F, Di Costanzo G, Folco U, Pronzato P, GONO (Italian Gruppo Oncologico del Nord-Ovest).
    Gynecol Oncol; 2004 May; 93(2):474-8. PubMed ID: 15099965
    [Abstract] [Full Text] [Related]

  • 16. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer.
    Kormosh N, Laktionov K, Antoshechkina M.
    Phytother Res; 2006 May; 20(5):424-5. PubMed ID: 16619374
    [Abstract] [Full Text] [Related]

  • 17. Reduction of CD45RA isoform expression and decrease in CD4 and CD8 receptor density in lymphocytes of patients with primary biliary cirrhosis.
    Musialik J, Michalkiewicz J, Petelenz M, Mazurek U, Mazur W, Madaliński K, Gonciarz Z.
    Scand J Gastroenterol; 2003 Apr; 38(4):421-6. PubMed ID: 12739715
    [Abstract] [Full Text] [Related]

  • 18. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome.
    Daniel V, Naujokat C, Sadeghi M, Weimer R, Renner F, Yildiz S, Opelz G.
    Transpl Int; 2008 Jul; 21(7):646-60. PubMed ID: 18298587
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M.
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [Abstract] [Full Text] [Related]

  • 20. [Selected lymphocyte subsets in Lime borreliosis: a preliminary study].
    Zajkowska JM, Hermanowska-Szpakowicz T, Kasprzycka E.
    Pol Merkur Lekarski; 1999 May; 6(35):259-62. PubMed ID: 10437395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.